Investing.com-- Merck&Company Inc (NYSE:MRK) is close to entering a $1.3 billion deal to buy Eyebiotech ... is expected to pay $1.3 billion in cash for the ophthalmology firm, and could pay ...

German drug company Merck KGaA said Monday it has struck a deal to buy U.S. biotech firm SpringWorks Therapeutics for around ...

NEW YORK/FRANKFURT (Reuters) - Germany's Merck KGaA has struck a deal to buy U.S. biotech ... The per share price in cash represents an equity value of about $3.9 billion, or an enterprise value ...